Our Products
Leading Manufacturer, Supplier & Retailer of Mounjaro 2.5mg, Mounjaro 7.5mg Injection, Zepbound Tirzepatide Injection and Erythropoietin Injection.
Mounjaro 2.5 mg refers to the 2.5 milligram starting dose of Mounjaro, a prescription injectable medicine whose active ingredient is tirzepatide. It’s given as a once-weekly subcutaneous injection (under the skin, often in the abdomen, thigh, or upper arm) and is primarily prescribed to improve blood sugar control in adults with type 2 diabetes. When used with diet and exercise, it can also support weight loss.
Zepbound is a prescription injectable medication containing tirzepatide, a dual GIP and GLP-1 receptor agonist. It is supplied as a single-dose, pre-filled injection pen and is approved for chronic weight management in adults with obesity or overweight with related medical conditions, under medical supervision.
Zepbound® is available in multiple strengths, including 5 mg, 7.5 mg, and 10 mg, allowing for gradual dose adjustment as prescribed. The injection is formulated as a clear, colorless solution intended for subcutaneous administration.
Manufactured by Eli Lilly and Company, Zepbound® is a prescription-only medicine, regulated and distributed according to regional health authority approvals.